Technique and short-term outcome of green light laser (KTP, 80W) vaporisation of the prostate.

OBJECTIVE Photoselective laser vaporisation prostatectomy with an 80-W potassium-titanyl-phosphate (KTP) laser is an effective procedure for men with symptomatic benign prostatic hyperplasia. The main advantages of the laser treatment are less blood loss and the short hospital stay. METHODS The DVD and photos show the main steps and difficulties of the procedure. All patients were evaluated preoperatively and postoperatively by using the International Prostate Symptom Score, volume of prostate, maximum flow rate, haemoglobin values, and postmicturition volume of residual urine. Days of bladder catheterisation, duration of the procedure, and prostate-specific antigen values were determined as well. RESULTS The results in 140 patients, who underwent KTP laser treatment, were evaluated. The mean age of the patients was 69+/-7.8 yr. Mean volume of prostates, mean operative time, and mean energy delivery were 43+/-22 ml, 53+/-16 min, and 181+/-58 kJ, respectively. The bladder catheter was removed usually on the first postoperative day. Preoperative haemoglobin values were just slightly higher at 14.4+/-1.3g/dl compared to the postoperative values of 13.9+/-1.4 g/dl. The most common complication, dysuria, was seen in 35 patients (25%), followed by mild haematuria in 21 patients (15%). CONCLUSIONS Photoselective laser vaporisation of the prostate is a treatment option in men who are at high risk for clinically significant bleeding. The procedure provides a high level of intraoperative and postoperative safety and seems to be comparable to transurethral resection of the prostate in the relief of obstructive symptoms.

[1]  D. Bostwick,et al.  High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. , 1997, Urology.

[2]  Surendra M Kumar,et al.  Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate. , 2005, The Journal of urology.

[3]  T. Gasser,et al.  Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. , 2007, European urology.

[4]  U. Nseyo,et al.  Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. , 2004, The Journal of urology.

[5]  J. Kabalin,et al.  Neodymium:YAG laser coagulation prostatectomy: 3 years of experience with 227 patients. , 1996, The Journal of urology.

[6]  D. M. Barrett,et al.  High power potassium-titanyl-phosphate laser vaporization prostatectomy. , 2000, The Journal of urology.

[7]  J. Lynch,et al.  Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prostatron Cooperative Study. , 1993, The Journal of urology.

[8]  R. Malek,et al.  Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. , 2003, Journal of endourology.

[9]  Scott Van Appledorn,et al.  KTP laser versus transurethral resection: early results of a randomized trial. , 2006, Journal of endourology.

[10]  S. Ahyai,et al.  Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. , 2007, European urology.

[11]  R. Kuntz Laser treatment of benign prostatic hyperplasia , 2007, World Journal of Urology.

[12]  P. Walsh,et al.  The development of human benign prostatic hyperplasia with age. , 1984, The Journal of urology.

[13]  Rainer Hofmann,et al.  Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. , 2006, European urology.

[14]  Amol P Mahajan,et al.  Peri‐operative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of literature , 2007, BJU international.

[15]  Andrew R. Girvan,et al.  Safety and efficacy of holmium: YAG laser lithotripsy in patients with bleeding diatheses , 2002 .

[16]  H. V. van Melick,et al.  Laser prostatectomy in patients on anticoagulant therapy or with bleeding disorders. , 2003, The Journal of urology.

[17]  A Hofstetter,et al.  Interstitial laser therapy outcomes in benign prostatic hyperplasia. , 1995, Journal of endourology.

[18]  D. Bostwick,et al.  Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. , 1996, Urology.

[19]  T. Gasser,et al.  [The 80 W potassium-titanium-phosphate (KTP) laser vaporization of the prostate. Technique and 6 month follow-up after 70 procedures]. , 2004, Der Urologe. Ausg. A.

[20]  M. Elhilali,et al.  Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. , 2007, European urology.

[21]  A. Hofstetter,et al.  Die 80-Watt-Kalium-Titanyl-Phosphat- (KTP-)Laservaporisation der Prostata , 2004, Der Urologe, Ausgabe A.

[22]  Tugcu Volkan,et al.  Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate. , 2005, European urology.

[23]  C C Schulman,et al.  Transurethral needle ablation (TUNA): safety, feasibility, and tolerance of a new office procedure for treatment of benign prostatic hyperplasia. , 1993, European urology.